Diabetes news
Sensors, medication, clinical studies, diet, exercise and complications: a clear summary of the latest news, always linked to the original source.
Endocrinologists highlight the impact of real-time glucose monitoring in type 2 diabetes
LIFE-ONE, the first published clinical study in Spain on real-time glucose monitoring with Dexcom sensors in people with type 2 diabetes on insulin, found improved glycemic control and quality of life after 12 weeks, though access still varies widely by region.
Read more →Brazil approves five new semaglutide injectable medicines for type 2 diabetes
Brazil's health regulator Anvisa authorized five new semaglutide-based injectable medicines — Owozy, Seemasun, Zempneo, Semavy and Orsema — for type 2 diabetes and obesity, after Ozempic's patent expired in the country.
Read more →Specialists call for treating obesity as a chronic disease to help prevent diabetes
At a scientific congress in Punta Cana attended by more than 250 specialists, experts argued for moving away from treating obesity as a habits problem and instead managing it as a chronic disease, given its close ties to type 2 diabetes and hypertension.
Read more →Weight loss doesn't always prevent type 2 diabetes, new study finds
A German study found that even after maintaining 8% weight loss for 9 years, a group of people at high metabolic risk still saw their blood glucose rise and their insulin secretion fall.
Read more →North Carolina preserves Medicaid coverage for obesity medications
The American Diabetes Association praised North Carolina's decision to preserve Medicaid coverage for FDA-approved obesity medications, which are also used to treat type 2 diabetes.
Read more →The kidney, an "early warning sensor" for cardiovascular risk in diabetes, according to Vithas
Vithas specialists warn that kidney disease in diabetes isn't just an isolated complication, but an amplifier of cardiovascular risk, with summer heat and dehydration adding an extra factor.
Read more →Panama hands out free glucose sensors to children with diabetes
Panama's Social Security Fund has started providing 14-day continuous glucose monitoring sensors to minors with diabetes, with alerts before a dangerous glucose drop.
Read more →Mexico authorizes the first type 2 diabetes pill with dual approval for obesity
COFEPRIS authorized a new oral treatment from Eli Lilly that in phase 3 trials achieved reductions of up to 2.2 points of HbA1c and an average 12.4% body weight loss.
Read more →The 2026 update for cardiologists prioritizes cardiorenal benefit when choosing type 2 diabetes treatment
The latest review reinforces a shift in approach: choosing drugs based on their cardiovascular and kidney benefit, even when glucose control is already acceptable.
Read more →ADA's 2026 standards reinforce 5-7% weight loss and the Mediterranean diet against prediabetes
The American Diabetes Association's update reaffirms structured follow-up for prediabetes, giving more weight to weight-loss programs, the Mediterranean diet and telemedicine.
Read more →How exercise helps restore mobility and improve diabetes control
An exercise program for people with diabetes showed improvements in muscle strength, pain, stiffness, balance and fall risk, as well as reinforcing everyday independence.
Read more →ADA's 2026 standards reinforce glucose and blood pressure control to slow retinopathy
The chapter on retinopathy, neuropathy and foot care in the 2026 Standards of Care in Diabetes stresses reaching glucose, blood pressure and lipid targets to reduce these complications.
Read more →A biochemical blood signature identifies people at higher risk of dying from diabetes
Researchers from the URV, IRB-CatSud and CIBEROBN have identified 9 blood metabolites, common to both type 2 diabetes and insulin resistance, associated with a higher risk of death.
Read more →Orforglipron now has a brand name: Foundayz, Lilly's pill for type 2 diabetes
Eli Lilly's oral drug, already authorized in Mexico, showed in the ACHIEVE-3 trial a reduction of up to 2.2 points in HbA1c and an average 9.2% body weight loss over 52 weeks.
Read more →An AI model predicts hospital hypoglycemia 24 hours in advance
Cedars-Sinai researchers developed an LSTM AI model that, using data from nearly 143,000 hospital admissions, predicts which patients are at risk of hypoglycemia up to 24 hours before it happens.
Read more →The exercise routine linked to a lower risk of type 2 diabetes, according to a study
An analysis using data from the Nurses' Health Study and the Health Professionals Follow-up Study found an association between a regular exercise routine and up to a 62% lower risk of developing type 2 diabetes.
Read more →Why type 2 diabetes is increasingly understood as an inflammatory disease too
There's growing consensus that, beyond a glucose regulation problem, type 2 diabetes involves chronic low-grade inflammation that feeds back into insulin resistance.
Read more →Gut microbiota, a new clue to understanding type 2 diabetes
Researchers identify a link between microbiota composition and glucose metabolism regulation.
Read more →A low-calorie Mediterranean diet combined with exercise cuts type 2 diabetes risk by 31%
The PREDIMED-Plus clinical trial, involving 4,746 adults with overweight or obesity and metabolic syndrome across more than 100 primary care centers in Spain, found a 31% reduction in type 2 diabetes risk with a low-calorie Mediterranean diet, moderate exercise and ongoing professional support.
Read more →Preventing diabetic retinopathy comes down to controlling glucose and blood pressure
Specialists stress that the best strategy against this eye complication remains prevention, rather than treating it once it has developed.
Read more →150 minutes of moderate exercise a week cut type 2 diabetes risk by 58%
A three-year program combining a low-fat diet with moderate physical activity showed a notable risk reduction in people predisposed to developing the disease.
Read more →UNAM scientists develop eye drops to treat diabetic retinopathy without injections
Researchers at UNAM's Institute of Neurobiology have developed vasoinhibin-based eye drops that aim to replace the intraocular injections currently used against diabetic retinopathy.
Read more →Breaking up sitting time every 30 minutes helps control blood glucose
Small active breaks throughout the day, like getting up to walk for a few minutes, are linked to improved glucose levels in people with diabetes.
Read more →Strict glycemic control remains the most effective strategy against diabetic neuropathy
The latest reviews confirm that comprehensive management of cardiovascular risk factors is the basis of prevention, while new neuromodulation techniques advance.
Read more →Gene therapy: a clinical trial aims to teach muscles to regulate glucose
Biotech company Kriya Therapeutics introduces insulin and glucokinase genes into skeletal muscle through a single intramuscular injection.
Read more →FDA approves Awiqli, the first weekly insulin for type 2 diabetes
Insulin icodec, marketed as Awiqli, becomes the first once-weekly basal insulin for adults with type 2 diabetes, with results comparable to daily insulins.
Read more →Swapping sedentary time for sleep or exercise lowers insulin resistance in teens
Research presented at the American Heart Association's EPI|Lifestyle 2026 sessions found that replacing 30 daily minutes of sedentary time with sleep or moderate-to-vigorous activity cut insulin resistance by nearly 15% in adolescents.
Read more →Stem cells without immunosuppression: Sana Biotechnology starts a phase 1 trial
The biotech company is advancing a stem-cell-derived cell therapy that aims to avoid the use of immunosuppressive drugs.
Read more →Abbott unveils a sensor able to measure glucose and ketones at the same time
The company showed off, at an international diabetes-technology conference, a dual sensor designed to catch diabetic ketoacidosis earlier.
Read more →Strength training improves glycemic control in type 2 diabetes
Several studies point to a significant drop in HbA1c in people with type 2 diabetes who add strength exercises to their routine.
Read more →Patient education increases screening for diabetic retinopathy and neuropathy
Health education programs are linked to a 33% increase in retinopathy checkups and a 38% increase in diabetic neuropathy checkups.
Read more →A large study links semaglutide to lower kidney and cardiovascular risk
A trial with more than 3,500 participants observed a 24% reduction in a composite of serious kidney events and cardiovascular death.
Read more →FDA approves bexagliflozin (Brenzavvy) for type 2 diabetes
This is a new sodium-glucose cotransporter 2 (SGLT2) inhibitor developed by TheracosBio to improve glycemic control.
Read more →Plant-based dietary patterns gain ground in diabetes guidelines
Available evidence links high-fiber, low-saturated-fat diets with a lower expression of cardiovascular risk factors.
Read more →Losing 5% to 10% of body weight improves metabolic control
A healthy eating plan combined with regular exercise can have a meaningful impact on glucose, blood pressure and lipid profile.
Read more →Glucose sensors in 2026: fewer calibrations and more accuracy
The new generation of continuous glucose monitors (CGM) reduces the need for finger-prick calibration and moves toward smarter, more connected systems.
Read more →The 2026 NICE guideline calls for individualized nutritional counseling
The British update on type 2 diabetes stresses person-centered care in nutrition too.
Read more →Chile approves tirzepatide for type 2 diabetes and weight management
The Public Health Institute (ISP) authorized this Lilly drug, which acts on two hormonal mechanisms related to glucose and appetite.
Read more →MiniMed Simplera Sync: an all-in-one disposable sensor
Medtronic's new sensor removes the need for extra adhesive tape and simplifies insertion to just two steps.
Read more →A project generates insulin-producing cells from human skin for type 1 diabetes
Research co-funded by the DiabetesCERO Foundation has managed to generate, from human skin, cells increasingly similar to the pancreas's beta cells, capable of producing insulin.
Read more →CagriSema and orforglipron, 2026's most anticipated treatments
Novo Nordisk and Eli Lilly are advancing new combinations and an oral GLP-1 agonist for obesity and type 2 diabetes.
Read more →Isaac, the sensor that promises to measure glucose through your breath with no finger pricks
Unveiled at CES 2026, this coin-sized device developed by PreEvnt aims to measure blood sugar non-invasively by analyzing the user's breath.
Read more →There are no articles in this category yet.